National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.
about
Sedative techniques for endoscopic retrograde cholangiopancreatographyAppropriate patient selection in the management of common bile duct stones: when not to do ERCPThe clinical impact and cost implication of endoscopic ultrasound on use of endoscopic retrograde cholangiopancreatography in a Canadian university hospital.Factors Associated with Diffusely Increased Splenic F-18 FDG Uptake in Patients with CholangiocarcinomaSomatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients.Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunctionReview of idiopathic pancreatitisRole of endoscopic retrograde cholangiopancreatography in acute pancreatitis.Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.Practice guidelines in acute pancreatitis.Single operator choledochoscopy and its role in daily endoscopy routineEvaluating ERCP is important but difficult.Application of a wire-guided side-viewing duodenoscope in total esophagectomy with colonic interpositionPost-endoscopic retrograde cholangiopancreatography pancreatitis.Multidisciplinary team meeting before therapeutic ERCP: A prospective study with 1,909 cases.Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial.Is ESR Important for Predicting Post-ERCP Pancreatitis?Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trialIntraoperative ERCP: What role does it have in the era of laparoscopic cholecystectomy?Spyglass direct visualization systemPost-ERCP pancreatitis and its prevention.Trends in the Use of Endoscopic Retrograde Cholangiopancreatography for the Management of Chronic Pancreatitis in the United StatesSolid state biliary manometry catheter: impact on diagnosis and post-study pancreatitis.Which patients with dilated common bile and/or pancreatic ducts have positive findings on EUS?Sphincter of Oddi and its dysfunction.Endoscopic versus laparoscopic treatment for choledocholithiasis: a prospective randomized controlled trial.Efficacy of Endoscopic Ultrasonography in Evaluation of Undetermined Etiology of Common Bile Duct Dilatation on Abdominal Ultrasonography.The functional sphincter of Oddi disorder.Efficacy of SpyGlass(TM)-directed biopsy compared to brush cytology in obtaining adequate tissue for diagnosis in patients with biliary strictures.Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.Therapeutic biliary and pancreatic endoscopy in Qatar- a five year retrospective audit.Endoscopy in the diagnosis and management of motility disorders.An appraisal of endoscopic retrograde cholangiopancreatography (ERCP) for pancreaticobiliary disease in children: our institutional experience in 231 cases.The usefulness of SpyGlass™ choledochoscopy in the diagnosis and treatment of biliary disorders.Improving ERCP quality and decreasing risk to patients and providers.Technical outcomes and complications of pediatric ERCP.The role of endoscopic retrograde cholangiopancreatography at an academic medical center in the era of less-invasive diagnostic tools.Follow-up to determine unplanned hospitalization and complications after endoscopic retrograde cholangiopancreatography.Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass.
P2860
Q24202878-BE9CAD2A-A406-4EAA-9DFA-A7827A305220Q30465856-E90BB675-EC13-4F6A-A9FA-BAB2AA43844EQ30490033-0186E407-C009-492D-80B3-6FD1BD3A11FBQ33639357-4FDCF08B-7AAF-487D-9ED0-882ADF2EC0A7Q33837450-DAC3112F-9CE8-49A6-BA74-AB48B03A0E71Q34134956-76986CDB-7913-40EE-9AF9-C3278CC3D1AEQ34146887-5DA5A8A2-08AE-4428-8268-15D926B00960Q34382873-D938FD11-4822-4C51-AEC3-BBE490BA3F3BQ34382881-A5C896F3-2C3B-439D-B498-135A34AA8DE9Q34390035-CABDDC37-C39B-43C4-96F6-492E0073C411Q34572933-CB34CF00-49A7-4608-A54C-3AE8A7B89AD0Q34725214-3A4251C1-EE38-4899-833C-6ED820A27283Q34739164-EE40FAB8-8E57-4BB6-BC2D-C31B6057E689Q34772124-D1E043FC-84DD-4043-8CC7-10FEB1362D7BQ35074284-50F388C1-877C-4736-8096-09DC681008BEQ35106888-B1538422-408D-45C3-91A3-0E7F093EFAD7Q35537814-0154DC1C-A25D-478A-801E-511CD1DD031AQ35591880-DB011862-A267-4F12-93EB-338A73171616Q35596336-76BC6CBD-CD7C-4F81-9514-0F2B6AD8BB19Q35630531-827B2187-CA75-48C6-A79F-1CA2C92C2CCCQ36195382-CEA0254B-62F3-4E6B-9FF1-D673F950FDDFQ36666312-24C96267-109E-4263-B997-C40C022A8631Q36777558-62FB7A60-A7BD-4513-83DF-3F495C1F675BQ36785195-0351F36C-8490-4429-890C-DB4319FFF1A7Q36848037-615D4AEF-D0B8-4E9E-A16E-DCCDBEFDADA3Q37243525-A16EFE7D-62CF-40CD-BC06-5B6763E496E3Q37418188-CA5E2BB3-E29D-4F78-88BB-AD82AF9FDD77Q37486206-917AB9A9-8F6D-4ED3-9C8B-893B2ED1D27AQ37682769-A20C87AE-D25D-4963-BAC0-0438BAA3CA48Q37700498-05531554-1B5A-424A-A5E5-AE4F3378DA07Q37701805-3C28A25C-9F13-4434-8E0B-30A78159A8DEQ37709493-8D76A686-15B9-4512-9F91-424506CEF984Q37834418-8197F0A4-4FB2-4649-BD3A-9259B2A189E4Q37848170-98BD8475-C405-414E-8565-A292AB6741E5Q38052076-FD599FCD-998F-41C1-B0C5-B4759DC50E2CQ38132277-35E71A84-87BE-4F5E-870E-75564599DBD0Q38352280-727AA93A-A971-4467-B276-9EA302D1A96EQ38457473-B5CD1049-9CBA-4014-A327-E3A46B7A3DF3Q39140429-1DA1925B-F125-420C-AFBB-23C4602B933EQ39294799-F22143B0-F824-4615-9051-52CF8EF2AA44
P2860
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
National Institutes of Health ...... therapy, January 14-16, 2002.
@ast
National Institutes of Health ...... therapy, January 14-16, 2002.
@en
type
label
National Institutes of Health ...... therapy, January 14-16, 2002.
@ast
National Institutes of Health ...... therapy, January 14-16, 2002.
@en
prefLabel
National Institutes of Health ...... therapy, January 14-16, 2002.
@ast
National Institutes of Health ...... therapy, January 14-16, 2002.
@en
P2093
P1476
National Institutes of Health ...... therapy, January 14-16, 2002.
@en
P2093
Alfred E McNair
Amnon Sonnenberg
Bruce R Bacon
David F Ransohoff
David Fleischer
Gail A Hecht
Jesse A Berlin
Linda Rabeneck
Michael Mulholland
Michael W Vannier
P304
P356
10.1016/S0016-5107(02)70351-9
P407
P577
2002-12-01T00:00:00Z